{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:54:34Z","timestamp":1772106874284,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The hemagglutinin (HA) of influenza viruses is a possible target for antiviral drugs because of its key roles in the initiation of infection. Although it was found that a natural compound, Stachyflin, inhibited the growth of H1 and H2 but not H3 influenza viruses in MDCK cells, inhibitory activity of the compound has not been assessed against H4-H16 influenza viruses and the precise mechanism of inhibition has not been clarified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Inhibitory activity of Stachyflin against H4-H16 influenza viruses, as well as H1-H3 viruses was examined in MDCK cells. To identify factors responsible for the susceptibility of the viruses to this compound, Stachyflin-resistant viruses were selected in MDCK cells and used for computer docking simulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>It was found that in addition to antiviral activity of Stachyflin against influenza viruses of H1 and H2 subtypes, it inhibited replication of viruses of H5 and H6 subtypes, as well as A(H1N1)pdm09 virus in MDCK cells. Stachyflin also inhibited the virus growth in the lungs of mice infected with A\/WSN\/1933 (H1N1) and A\/chicken\/Ibaraki\/1\/2005 (H5N2). Substitution of amino acid residues was found on the HA2 subunit of Stachyflin-resistant viruses. Docking simulation indicated that D37, K51, T107, and K121 are responsible for construction of the cavity for the binding of the compound. In addition, 3-dimensional structure of the cavity of the HA of Stachyflin-susceptible virus strains was different from that of insusceptible virus strains.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Antiviral activity of Stachyflin was found against A(H1N1)pdm09, H5, and H6 viruses, and identified a potential binding pocket for Stachyflin on the HA. The present results should provide us with useful information for the development of HA inhibitors with more effective and broader spectrum.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1743-422x-10-118","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T06:14:20Z","timestamp":1366092860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes"],"prefix":"10.1186","volume":"10","author":[{"given":"Yurie","family":"Motohashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Okamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Noshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihito","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,16]]},"reference":[{"key":"2119_CR1","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","volume":"4","author":"AJ Hay","year":"1985","unstructured":"Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH: The molecular basis of the specific anti-influenza action of Amantadine. EMBO J 1985, 4: 3021-3024.","journal-title":"EMBO J"},{"key":"2119_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.med.59.061506.213121","volume":"59","author":"A Moscona","year":"2008","unstructured":"Moscona A: Medical management of influenza infection. Annu Rev Med 2008, 59: 397-413. 10.1146\/annurev.med.59.061506.213121","journal-title":"Annu Rev Med"},{"key":"2119_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","volume":"69","author":"LH Pinto","year":"1992","unstructured":"Pinto LH, Holsinger LJ, Lamb RA: Influenza virus M2 protein has ion channel activity. Cell 1992, 69: 517-528. 10.1016\/0092-8674(92)90452-I","journal-title":"Cell"},{"key":"2119_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","volume":"61","author":"P Palese","year":"1974","unstructured":"Palese P, Tobita K, Ueda M, Compans RW: Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 1974, 61: 397-410. 10.1016\/0042-6822(74)90276-1","journal-title":"Virology"},{"key":"2119_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","volume":"355","author":"LV Gubareva","year":"2000","unstructured":"Gubareva LV, Kaiser L, Hayden FG: Influenza virus neuraminidase inhibitors. Lancet 2000, 355: 827-835. 10.1016\/S0140-6736(99)11433-8","journal-title":"Lancet"},{"key":"2119_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Frederick GH, Sugaya N, Kawaoka Y: Resistant influenza a viruses in children treated with oseltamivir: descriptive study. Lancet 2004, 364: 759-765. 10.1016\/S0140-6736(04)16934-1","journal-title":"Lancet"},{"key":"2119_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0005-2736(02)00511-4","volume":"1565","author":"D Shental-Bechor","year":"2002","unstructured":"Shental-Bechor D, Danieli T, Henis Y, Ben-Tal N: Long-range effects on the binding of the influenza HA to receptors are mediated by changes in the stability of a metastable HA conformation. Biochim Biophys Acta 2002, 1565: 81-89. 10.1016\/S0005-2736(02)00511-4","journal-title":"Biochim Biophys Acta"},{"key":"2119_CR8","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1016\/j.bmcl.2010.04.060","volume":"20","author":"F Feng","year":"2010","unstructured":"Feng F, Miura N, Isoda N, Sakoda Y, Okamatsu M, Kida H, Nishimura S: Novel trivalent anti-influenza reagent. Bioorg Med Chem Lett 2010, 20: 3772-3776. 10.1016\/j.bmcl.2010.04.060","journal-title":"Bioorg Med Chem Lett"},{"key":"2119_CR9","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/AAC.47.8.2518-2525.2003","volume":"47","author":"BR O'Keefe","year":"2003","unstructured":"O'Keefe BR, Smee DF, Turpin JA, Saucedo CJ, Gustafson KR, Mori T, Blakeslee D, Buckheit R, Boyd MR: Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob Agents Chemother 2003, 47: 2518-2525. 10.1128\/AAC.47.8.2518-2525.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2119_CR10","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/jvi.71.5.4062-4070.1997","volume":"71","author":"G Luo","year":"1997","unstructured":"Luo G, Torri A, Harte WE, Danetz S, Cianci C, Tiley L, Day S, Mullaney D, Yu KL, Ouellet C, Dextraze P, Meanwell N, Colonno R, Krystal M: Molecular mechanism underlying the action of a novel fusion inhibitor of influenza a virus. J Virol 1997, 71: 4062-4070.","journal-title":"J Virol"},{"key":"2119_CR11","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1128\/JVI.02325-09","volume":"84","author":"E Vanderlinden","year":"2010","unstructured":"Vanderlinden E, G\u00f6ktas F, Cesur Z, Froeyen M, Reed ML, Russell CJ, Cesur N, Naesens L: Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin. J Virol 2010, 84: 4277-4288. 10.1128\/JVI.02325-09","journal-title":"J Virol"},{"key":"2119_CR12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/JVI.73.1.140-151.1999","volume":"73","author":"SJ Plotch","year":"1999","unstructured":"Plotch SJ, O'Hara B, Morin J, Palant O, LaRocque J, Bloom JD, Lang SA Jr, DiGrandi MJ, Bradley M, Nilakantan R, Gluzman Y: Inhibition of influenza a virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin. J Virol 1999, 73: 140-151.","journal-title":"J Virol"},{"key":"2119_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s007050050552","volume":"144","author":"J Yoshimoto","year":"1999","unstructured":"Yoshimoto J, Kakui M, Iwasaki H, Fujiwara T, Sugimoto H, Hattori N: Identification of a novel HA conformational change inhibitor of human influenza virus. Arch Virol 1999, 144: 865-878. 10.1007\/s007050050552","journal-title":"Arch Virol"},{"key":"2119_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1348-0421.2000.tb02549.x","volume":"44","author":"J Yoshimoto","year":"2000","unstructured":"Yoshimoto J, Kakui M, Iwasaki H, Sugimoto H, Fujiwara T, Hattori N: Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, stachyflin. Microbiol Immunol 2000, 44: 677-685.","journal-title":"Microbiol Immunol"},{"key":"2119_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1023\/A:1018983715982","volume":"16","author":"S Yagi","year":"1999","unstructured":"Yagi S, Ono J, Yoshimoto J, Sugita K, Hattori N, Fujioka T, Fujiwara T, Sugimoto H, Hirano K, Hashimoto N: Development of anti-influenza virus drugs I: improvement of oral absorption and in vivo anti-influenza activity of stachyflin and its derivatives. Pharm Res 1999, 16: 1041-1046. 10.1023\/A:1018983715982","journal-title":"Pharm Res"},{"key":"2119_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1211\/0022357001777225","volume":"52","author":"J Yoshimoto","year":"2000","unstructured":"Yoshimoto J, Yagi S, Ono J, Sugita K, Hattori N, Fujita T, Fujiwara T, Sugimoto H, Hashimoto N: Development of anti-influenza drugs: II. Improvement of oral and intranasal absorption and the anti-influenza activity of stachyflin derivatives. J Pharm Pharmacol 2000, 52: 1247-1255. 10.1211\/0022357001777225","journal-title":"J Pharm Pharmacol"},{"key":"2119_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF01311693","volume":"76","author":"H Kida","year":"1983","unstructured":"Kida H, Webster RG, Yanagawa R: Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of a\/seal\/Massachusetts\/1\/80 (H7N7) influenza virus. Arch Virol 1983, 76: 91-99. 10.1007\/BF01311693","journal-title":"Arch Virol"},{"key":"2119_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/cb200332k","volume":"7","author":"H Yanagita","year":"2012","unstructured":"Yanagita H, Yamamoto N, Fuji H, Liu X, Ogata M, Yokota M, Takaku H, Hasegawa H, Odagiri T, Tashiro M, Hoshino T: Mechanism of drug resistance of hemagglutinin of influenza virus and potent scaffolds inhibiting its function. ACS Chem Biol 2012, 7: 552-562. 10.1021\/cb200332k","journal-title":"ACS Chem Biol"},{"key":"2119_CR19","doi-asserted-by":"publisher","first-page":"17736","DOI":"10.1073\/pnas.0807142105","volume":"105","author":"RJ Russell","year":"2008","unstructured":"Russell RJ, Kerry PS, Stevens DJ, Steinhauer DA, Martin SR, Gamblin SJ, Skehel JJ: Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci USA 2008, 105: 17736-17741. 10.1073\/pnas.0807142105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2119_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ejphar.2011.04.013","volume":"660","author":"S Liu","year":"2011","unstructured":"Liu S, Li R, Zhang R, Chan CC, Xi B, Zhu Z, Yang J, Poon VK, Zhou J, Chen M: CL-385319 inhibits H5N1 avian influenza a virus infection by blocking viral entry. Eur J Pharmacol 2011, 660: 460-467. 10.1016\/j.ejphar.2011.04.013","journal-title":"Eur J Pharmacol"},{"key":"2119_CR21","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1128\/AAC.01667-08","volume":"53","author":"EA Govorkova","year":"2009","unstructured":"Govorkova EA, Ilyushina NA, McClaren JL, Naipospos TS, Douangngeun B, Webster RG: Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrob Agents Chemother 2009, 53: 3088-3096. 10.1128\/AAC.01667-08","journal-title":"Antimicrob Agents Chemother"},{"key":"2119_CR22","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1096\/fj.06-7052hyp","volume":"21","author":"PS Rachakonda","year":"2007","unstructured":"Rachakonda PS, Veit M, Korte T, Ludwig K, B\u00f6ttcher C, Huang Q, Schmidt MF, Herrmann A: The relevance of salt bridges for the stability of the influenza virus hemagglutinin. FASEB J 2007, 21: 995-1002. 10.1096\/fj.06-7052hyp","journal-title":"FASEB J"},{"key":"2119_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1042\/BST0360043","volume":"36","author":"DS Mueller","year":"2008","unstructured":"Mueller DS, Kampmann T, Yennamalli R, Young PR, Kobe B, Mark AE: Histidine protonation and the activation of viral fusion proteins. Biochem Soc Trans 2008, 36: 43-45. 10.1042\/BST0360043","journal-title":"Biochem Soc Trans"},{"key":"2119_CR24","doi-asserted-by":"publisher","first-page":"13910","DOI":"10.1073\/pnas.96.24.13910","volume":"96","author":"JW Drake","year":"1999","unstructured":"Drake JW, Holland JJ: Mutation rates among RNA viruses. Proc Natl Acad Sci USA 1999, 96: 13910-13913. 10.1073\/pnas.96.24.13910","journal-title":"Proc Natl Acad Sci USA"},{"key":"2119_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.7164\/antibiotics.55.239","volume":"55","author":"K Minagawa","year":"2002","unstructured":"Minagawa K, Kouzuki S, Tani H, Ishii K, Tanimoto T, Terui Y, Kamigauchi T: Novel stachyflin derivatives from stachybotrys sp. RF-7260. Fermentation, isolation, structure elucidation and biological activities. J Antibiot (Tokyo) 2002, 55: 239-248. 10.7164\/antibiotics.55.239","journal-title":"J Antibiot (Tokyo)"},{"key":"2119_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02123574","volume":"162","author":"K Tobita","year":"1975","unstructured":"Tobita K: Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses. Med Microbiol Immunol 1975, 162: 23-27. 10.1007\/BF02123574","journal-title":"Med Microbiol Immunol"},{"key":"2119_CR27","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H: A simple method of estimating fifty per cent endpoints. Am J Hyg 1938, 27: 493-497.","journal-title":"Am J Hyg"},{"key":"2119_CR28","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/nar\/5.4.1207","volume":"5","author":"JJ Skehel","year":"1978","unstructured":"Skehel JJ, Hay AJ: Nucleotide sequences at the 5\u2019 termini of influenza virus RNAs and their transcripts. Nucleic Acids Res 1978, 5: 1207-1219. 10.1093\/nar\/5.4.1207","journal-title":"Nucleic Acids Res"},{"key":"2119_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/viro.1999.0140","volume":"267","author":"E Hoffmann","year":"2000","unstructured":"Hoffmann E, Neumann G, Hobom G, Webster RG, Kawaoka Y: \"Ambisense\" approach for the generation of influenza a virus: vRNA and mRNA synthesis from one template. Virology 2000, 267: 310-317. 10.1006\/viro.1999.0140","journal-title":"Virology"},{"key":"2119_CR30","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1073\/pnas.100133697","volume":"97","author":"E Hoffmann","year":"2000","unstructured":"Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG: A DNA transfection system for generation of influenza a virus from eight plasmids. Proc Natl Acad Sci USA 2000, 97: 6108-6113. 10.1073\/pnas.100133697","journal-title":"Proc Natl Acad Sci USA"},{"key":"2119_CR31","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1128\/JVI.01879-08","volume":"83","author":"R Manzoor","year":"2009","unstructured":"Manzoor R, Sakoda Y, Nomura N, Tsuda Y, Ozaki H, Okamatsu M, Kida H: PB2 Protein of a highly pathogenic avian influenza virus strain a\/chicken\/Yamaguchi\/7\/2004 (H5N1) determines its replication potential in pigs. J Virol 2009, 83: 1572-1578. 10.1128\/JVI.01879-08","journal-title":"J Virol"},{"key":"2119_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.virusres.2008.12.005","volume":"140","author":"Y Tsuda","year":"2009","unstructured":"Tsuda Y, Isoda N, Sakoda Y, Kida H: Factors responsible for plaque formation of a\/duck\/Siberia\/272\/1998 (H13N6) influenza virus on MDCK cells. Virus Res 2009, 140: 194-198. 10.1016\/j.virusres.2008.12.005","journal-title":"Virus Res"},{"key":"2119_CR33","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1093\/nar\/gkg543","volume":"31","author":"N Eswar","year":"2003","unstructured":"Eswar N, John B, Mirkovic N, Fiser A, Ilyin VA, Pieper U, Stuart AC, Marti-Renom MA, Madhusudhan MS, Yerkovich B, Sali A: Tools for comparative protein structure modeling and analysis. Nucleic Acids Res 2003, 31: 3375-3380. 10.1093\/nar\/gkg543","journal-title":"Nucleic Acids Res"},{"key":"2119_CR34","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"MY Shen","year":"2006","unstructured":"Shen MY, Sali A: Statistical potential for assessment and prediction of protein structures. Protein Sci 2006, 15: 2507-2524. 10.1110\/ps.062416606","journal-title":"Protein Sci"},{"key":"2119_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowsk","year":"1993","unstructured":"Laskowsk RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993, 26: 283-291. 10.1107\/S0021889892009944","journal-title":"J Appl Cryst"},{"key":"2119_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","volume":"277","author":"D Eisenberg","year":"1997","unstructured":"Eisenberg D, L\u00fcthy R, Bowie JU: VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol 1997, 277: 396-404.","journal-title":"Methods Enzymol"},{"key":"2119_CR37","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1021\/jm051197e","volume":"49","author":"R Thomsen","year":"2006","unstructured":"Thomsen R, Christensen MH: MolDock: a new technique for high-accuracy molecular docking. J Med Chem 2006, 49: 3315-3321. 10.1021\/jm051197e","journal-title":"J Med Chem"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:02:56Z","timestamp":1630540976000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,16]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2119"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-118","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,16]]},"assertion":[{"value":"28 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"118"}}